Preparation Study Guide: Comprehensive 150-
Question Practice Exam with Expert Rationales
for Advanced Psychiatric-Mental Health Nurse
Practitioner Board Certification Success a well
detailed one written and graded
A+ upgraded
Instructions
This comprehensive practice examination consists of 150 multiple-choice questions designed to
mirror the difficulty, format, and content distribution of the ANCC PMHNP-BC certification
examination. Questions are written at an advanced/hard difficulty level and target PMHNP
students and professionals preparing for board certification. Each question includes one correct
answer with a detailed rationale explaining both the correct choice and why the distractors are
incorrect. The examination covers all five ANCC PMHNP domains: Scientific Foundation,
Advanced Practice Skills, Diagnosis and Treatment, Psychotherapy and Related Therapies, and
Ethical and Legal Principles.
Section I: Scientific Foundation (Questions 1–30)
1. A 34-year-old female with treatment-resistant depression is being evaluated for potential
augmentation strategies. She has been on escitalopram 20 mg daily for 12 weeks with partial
response. Which of the following neurobiological mechanisms best explains the rationale for
adding a second-generation antipsychotic as an augmentation agent?
A. Dopamine D2 receptor antagonism in the mesolimbic pathway
B. Serotonin 5-HT2A receptor antagonism enhancing noradrenergic and dopaminergic
transmission
C. Partial agonism at dopamine D2 receptors in the prefrontal cortex
D. N-methyl-D-aspartate (NMDA) receptor antagonism at the glycine site
,Correct Answer: B
Rationale: Second-generation antipsychotics augment antidepressants primarily through 5-
HT2A receptor antagonism, which disinhibits noradrenergic and dopaminergic release in the
prefrontal cortex, improving mood and cognitive symptoms. Option A describes the mechanism
of typical antipsychotics and is associated with extrapyramidal symptoms, not antidepressant
augmentation. Option C describes aripiprazole's partial D2 agonism, which is a specific
mechanism but not the primary rationale for augmentation across all SGAs. Option D describes
ketamine/esketamine's mechanism, which is a different augmentation strategy.
2. A 56-year-old male with bipolar I disorder is maintained on lithium 900 mg daily. His serum
lithium level is 1.2 mEq/L, and he reports new-onset tremor, nausea, and polyuria. Which of
the following best describes the primary mechanism of lithium-induced nephrogenic diabetes
insipidus?
A. Inhibition of adenylate cyclase in the collecting duct
B. Downregulation of aquaporin-2 water channels in the collecting duct
C. Antagonism of vasopressin V2 receptors in the distal tubule
D. Increased sodium reabsorption in the loop of Henle
Correct Answer: B
Rationale: Lithium induces nephrogenic diabetes insipidus by downregulating aquaporin-2
water channel expression in the renal collecting duct, reducing the kidney's response to
antidiuretic hormone. Option A is incorrect because lithium does not directly inhibit adenylate
cyclase; rather, it interferes with the signaling cascade downstream. Option C is incorrect
because lithium does not directly antagonize V2 receptors. Option D describes a different
mechanism unrelated to lithium's effect on water balance.
3. A 28-year-old female presents with symptoms of depression, fatigue, and weight gain.
Laboratory studies reveal TSH 6.8 mIU/L (normal 0.4–4.0), free T4 0.6 ng/dL (normal 0.8–1.8).
Which of the following pathophysiological mechanisms best explains her depressive
symptoms?
A. Decreased serotonin synthesis due to reduced tryptophan availability
B. Increased dopamine metabolism in the mesolimbic pathway
C. Reduced norepinephrine reuptake in the locus coeruleus
D. Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis
,Correct Answer: A
Rationale: Hypothyroidism reduces serotonin synthesis through decreased tryptophan
availability and altered thyroid hormone regulation of serotonin receptors. Option B is incorrect
because dopamine metabolism is not primarily affected in hypothyroidism. Option C is incorrect
because norepinephrine reuptake is not the primary mechanism. Option D describes HPA axis
hyperactivity seen in melancholic depression, not hypothyroidism.
4. Which neurotransmitter system is most directly implicated in the pathophysiology of
obsessive-compulsive disorder (OCD) based on the efficacy of pharmacological interventions?
A. Dopaminergic system in the nigrostriatal pathway
B. Serotonergic system in the cortico-striato-thalamo-cortical circuit
C. Noradrenergic system in the locus coeruleus
D. GABAergic system in the amygdala
Correct Answer: B
Rationale: OCD is primarily associated with dysregulation of the serotonergic system within the
cortico-striato-thalamo-cortical (CSTC) circuit, which explains the efficacy of SSRIs in treatment.
Option A is incorrect; while dopamine may play a secondary role, the primary system is
serotonergic. Option C is incorrect as the noradrenergic system is more implicated in anxiety
and arousal. Option D is incorrect; GABAergic dysfunction is more associated with generalized
anxiety.
5. A 72-year-old male with Alzheimer's disease is started on donepezil. Which of the following
best describes the mechanism of action of this medication?
A. Inhibition of acetylcholinesterase, increasing acetylcholine availability in the synaptic cleft
B. Antagonism of N-methyl-D-aspartate (NMDA) receptors
C. Inhibition of monoamine oxidase type B
D. Agonism at nicotinic acetylcholine receptors
Correct Answer: A
Rationale: Donepezil is a reversible acetylcholinesterase inhibitor that increases acetylcholine
availability in the synaptic cleft, compensating for the cholinergic deficit seen in Alzheimer's
disease. Option B describes memantine's mechanism. Option C describes selegiline's
mechanism. Option D is incorrect; donepezil does not directly agonize nicotinic receptors.
, 6. A 45-year-old male with schizophrenia has been on haloperidol 10 mg daily for 6 months.
He now presents with akathisia, rigidity, and a resting tremor. Which of the following
neuroanatomical pathways is most responsible for these extrapyramidal symptoms?
A. Mesolimbic pathway
B. Mesocortical pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
Correct Answer: C
Rationale: The nigrostriatal pathway, which projects from the substantia nigra to the striatum, is
responsible for motor control. Dopamine D2 receptor blockade in this pathway causes
extrapyramidal symptoms including akathisia, rigidity, and tremor. Option A (mesolimbic) is
implicated in psychosis and is the target for antipsychotic efficacy. Option B (mesocortical) is
involved in cognitive and affective symptoms. Option D (tuberoinfundibular) regulates prolactin
release.
7. A 32-year-old female with panic disorder is prescribed a benzodiazepine for acute symptom
management. Chronic use of this medication class leads to tolerance primarily through which
mechanism?
A. Downregulation of GABA-A receptor subunits
B. Increased GABA reuptake from the synaptic cleft
C. Decreased GABA synthesis in presynaptic neurons
D. Upregulation of glutamate receptors
Correct Answer: A
Rationale: Chronic benzodiazepine use leads to tolerance through downregulation and
internalization of GABA-A receptor subunits, reducing the receptor's sensitivity to GABA. Option
B is incorrect; benzodiazepines do not affect GABA reuptake. Option C is incorrect; GABA
synthesis is not primarily affected. Option D describes an indirect consequence but is not the
primary tolerance mechanism.
8. Which of the following genetic inheritance patterns is characteristic of Huntington's
disease?